Airable - OSA V1.0

  • Research type

    Research Study

  • Full title

    Airable technology for the monitoring of respiratory mechanics during sleep. A cross-sectional proof-of-concept study.

  • IRAS ID

    349254

  • Contact name

    Christopher Turnbull

  • Contact email

    christopher.turnbull@ndm.ox.ac.uk

  • Sponsor organisation

    University of Oxford / Research Governance, Ethics and Assurance

  • Duration of Study in the UK

    0 years, 3 months, 0 days

  • Research summary

    Obstructive sleep apnoea (OSA) is a condition where the throat repeatedly closes during sleep, causing loud snoring
    and disrupted sleep. This leads to poor sleep quality, excessive sleepiness, and risk of car accidents. OSA also
    contributes to high blood pressure, heart problems, and higher mortality rates. Around 1 billion adults globally have
    OSA, including 8 million in the UK, but most are undiagnosed and untreated, risking serious health issues.
    The best way to diagnose OSA is through an overnight sleep study in a lab or at home, which uses sensors to monitor
    breathing, oxygen levels, and heart rate. There is a shortage of capacity for sleep studies in the UK, with only 16,000
    tests done monthly. At this rate, it would take decades to find everybody with OSA. There is a clear need for new
    diagnostic methods.
    New devices, including the Sunrise, AcuPebble, Brizzy, and WatchPAT are available. However, these still require people
    to wear a device (wearable) and collect equipment either from hospital or via the post. Airable technologies work with
    signals transmitted through the air, such as sound or movement via technologies including sonar and radar.
    Reviva Softworks is a software company that make apps for tracking sleep such as SnoreLab and Sleepwave. They
    have developed a patented airable technology called PureTone that tracks movement and is currently used in a smart
    alarm app, Sleepwave. PureTone technology has been shown to be able to measure breathing rate and pattern in the
    daytime, showing potential as an Airable technology for the identification of OSA. PureTone has not yet been tested as
    an Airable technology in people with suspected obstructive sleep apnoea (OSA). This study aims to provide proof of
    concept that PureTone can monitor respiratory mechanics overnight by comparing it to home sleep tests in patients
    suspected of having OSA.

  • REC name

    South East Scotland REC 01

  • REC reference

    25/SS/0098

  • Date of REC Opinion

    3 Dec 2025

  • REC opinion

    Further Information Favourable Opinion